These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12742556

  • 1. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
    Breitkopf DM, Rosen MP, Young SL, Nagamani M.
    Contraception; 2003 May; 67(5):349-53. PubMed ID: 12742556
    [Abstract] [Full Text] [Related]

  • 2. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M, Almström E, Högstedt S, Nabrink M.
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [Abstract] [Full Text] [Related]

  • 3. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM, Thomas CM, Borm GF, Hollanders JM, Rolland R.
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [Abstract] [Full Text] [Related]

  • 4. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N.
    Cochrane Database Syst Rev; 2015 Apr 28; 2015(4):CD010334. PubMed ID: 25918921
    [Abstract] [Full Text] [Related]

  • 5. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Apr 28; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Apr 28; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 7. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun 28; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol.
    Cullberg G.
    Acta Obstet Gynecol Scand Suppl; 1985 Jun 28; 133():1-30. PubMed ID: 3161265
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb 28; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 10. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec 28; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 11. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A, Gallardo E.
    Fertil Steril; 1991 May 28; 55(5):877-81. PubMed ID: 1827074
    [Abstract] [Full Text] [Related]

  • 12. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
    Oner G, Muderris II.
    Contraception; 2011 Nov 28; 84(5):508-11. PubMed ID: 22018126
    [Abstract] [Full Text] [Related]

  • 13. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P.
    Contraception; 1983 Jun 28; 27(6):577-90. PubMed ID: 6225622
    [Abstract] [Full Text] [Related]

  • 14. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
    Mango D, Ricci S, Manna P, Miggiano GA, Serra GB.
    Contraception; 1996 Mar 28; 53(3):163-70. PubMed ID: 8689881
    [Abstract] [Full Text] [Related]

  • 15. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.
    Lancet; 1999 Dec 11; 354(9195):2036-40. PubMed ID: 10636369
    [Abstract] [Full Text] [Related]

  • 16. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
    Jung-Hoffmann C, Kuhl H.
    Am J Obstet Gynecol; 1987 Jan 11; 156(1):199-203. PubMed ID: 2948387
    [Abstract] [Full Text] [Related]

  • 17. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM, de Souza JC, da Silva AR, de Acosta OM, Alvarez F, Brache V, Garza Flores J, Vasquez-Estrada L, Santo R, Bassol S.
    Clin Pharmacol Ther; 1993 Jan 11; 53(1):65-75. PubMed ID: 8422744
    [Abstract] [Full Text] [Related]

  • 18. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA, Demers LM, Applebaum-Bowden D, Lenker R.
    Contraception; 1991 Aug 11; 44(2):113-24. PubMed ID: 1893706
    [Abstract] [Full Text] [Related]

  • 19. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
    Venturoli S, Porcu E, Gammi L, Fabbri R, Paradisi R, Flamigni C, Patrono D, Capelli M, Paoletti C.
    Acta Eur Fertil; 1988 Aug 11; 19(3):129-34. PubMed ID: 2976224
    [Abstract] [Full Text] [Related]

  • 20. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
    Nappi C, Farace MJ, Leone F, Minutolo M, Tommaselli AP, Montemagno U.
    Eur J Obstet Gynecol Reprod Biol; 1987 Jul 11; 25(3):209-19. PubMed ID: 2956138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.